New Results
Human Als3p Antibodies are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
View ORCID ProfilePriya Uppuluri, Shakti Singh, Abdullah Alqarihi, Clint S. Schmidt, John P. Hennessey Jr., Michael R. Yeaman, Scott G. Filler, John E. Edwards, Ashraf S. Ibrahim
doi: https://doi.org/10.1101/324483
Priya Uppuluri
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
2David Geffen School of Medicine at University of California, Los Angeles, CA
Shakti Singh
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
Abdullah Alqarihi
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
Clint S. Schmidt
3NovaDigm Therapeutics, Brookline, Massachusetts, USA
John P. Hennessey Jr.
3NovaDigm Therapeutics, Brookline, Massachusetts, USA
Michael R. Yeaman
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
2David Geffen School of Medicine at University of California, Los Angeles, CA
Scott G. Filler
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
2David Geffen School of Medicine at University of California, Los Angeles, CA
John E. Edwards
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
2David Geffen School of Medicine at University of California, Los Angeles, CA
Ashraf S. Ibrahim
1Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles 8 (UCLA) Medical Center, Torrance, California, USA
2David Geffen School of Medicine at University of California, Los Angeles, CA
Article usage
Posted May 17, 2018.
Human Als3p Antibodies are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
Priya Uppuluri, Shakti Singh, Abdullah Alqarihi, Clint S. Schmidt, John P. Hennessey Jr., Michael R. Yeaman, Scott G. Filler, John E. Edwards, Ashraf S. Ibrahim
bioRxiv 324483; doi: https://doi.org/10.1101/324483
Human Als3p Antibodies are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
Priya Uppuluri, Shakti Singh, Abdullah Alqarihi, Clint S. Schmidt, John P. Hennessey Jr., Michael R. Yeaman, Scott G. Filler, John E. Edwards, Ashraf S. Ibrahim
bioRxiv 324483; doi: https://doi.org/10.1101/324483
Subject Area
Subject Areas
- Biochemistry (11697)
- Bioengineering (8714)
- Bioinformatics (29114)
- Biophysics (14922)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14135)
- Epidemiology (2067)
- Evolutionary Biology (18260)
- Genetics (12214)
- Genomics (16758)
- Immunology (11838)
- Microbiology (27986)
- Molecular Biology (11544)
- Neuroscience (60774)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3226)
- Physiology (4935)
- Plant Biology (10380)
- Synthetic Biology (2876)
- Systems Biology (7331)
- Zoology (1642)